The number of people with diabetes is growing every year
Medical news: growing interest in type 2 diabetes remission
Medical news: interest in type 2 diabetes remission is growing.
⠀
Just a few years ago, doctors only talked about “glucose control,” but in 2023–2024, the global diabetes community is increasingly using another word: remission. This is a condition in which a person with type 2 diabetes achieves normal sugar levels (HbA1c <6.5%) without drug therapy for ≥3–6 months. And although until recently this seemed like science fiction, studies show that remission is real — especially if intervention is timely.
📊 A review in Diabetes Care (2021) emphasizes that patients with “young” diabetes have the best chance of remission in the first 3–5 years after diagnosis. This is a window of opportunity when the metabolic system can still be “reset.”
🔬 New trends in medicine focus on restoring β-cell function and glucose sensitivity, rather than simply lowering sugar levels. Innovative drugs have emerged:
GLP-1 analogues, which affect appetite and insulin secretion.
GKA activators — for example, dorzaglatin (Hua Medicine, China), which restores the activity of glucokinase — the main sensor of glucose levels in the liver and pancreas.
Combinations with natural nutraceuticals such as berberine, which activates AMPK and improves glucose utilization.⠀
This has given rise to a new approach — metabolic remission: not just “masking the symptoms,” but restoring the body's ability to regulate sugar on its own. In this sense, diabetes is increasingly seen not as a death sentence, but as a condition that can be reversed.
💡 A review in Nature Reviews Endocrinology (2023) emphasizes that it is the combination of early diagnosis, individualized therapy, and lifestyle — diet, physical activity, sleep, stress management — that is the key to long-term remission.
⠀
Just a few years ago, doctors only talked about “glucose control,” but in 2023–2024, the global diabetes community is increasingly using another word: remission. This is a condition in which a person with type 2 diabetes achieves normal sugar levels (HbA1c <6.5%) without drug therapy for ≥3–6 months. And although until recently this seemed like science fiction, studies show that remission is real — especially if intervention is timely.
📊 A review in Diabetes Care (2021) emphasizes that patients with “young” diabetes have the best chance of remission in the first 3–5 years after diagnosis. This is a window of opportunity when the metabolic system can still be “reset.”
🔬 New trends in medicine focus on restoring β-cell function and glucose sensitivity, rather than simply lowering sugar levels. Innovative drugs have emerged:
GLP-1 analogues, which affect appetite and insulin secretion.
GKA activators — for example, dorzaglatin (Hua Medicine, China), which restores the activity of glucokinase — the main sensor of glucose levels in the liver and pancreas.
Combinations with natural nutraceuticals such as berberine, which activates AMPK and improves glucose utilization.⠀
This has given rise to a new approach — metabolic remission: not just “masking the symptoms,” but restoring the body's ability to regulate sugar on its own. In this sense, diabetes is increasingly seen not as a death sentence, but as a condition that can be reversed.
💡 A review in Nature Reviews Endocrinology (2023) emphasizes that it is the combination of early diagnosis, individualized therapy, and lifestyle — diet, physical activity, sleep, stress management — that is the key to long-term remission.
- The outlook is clear: medicine is shifting its focus from “treating chronic disease” to restoring metabolic health. This means that in a few years, the word “remission” may become the new goal of diabetes therapy — not a dream, but the norm.